Endothelial FoxM1 mediates bone marrow progenitor cell-induced vascular repair and resolution of inflammation following inflammatory lung injury

Stem Cells

Volumn 32, Issue 7, 2014, Pages 1855-1864

  Zhao, Yidan D ^a   Huang, Xiaojia ^a,b   Yi, Fan ^a   Dai, Zhiyu ^a   Qian, Zhijian ^a   Tiruppathi, Chinnaswamy ^a   Tran, Khiem ^a   Zhao, You Yang ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Acute respiratory distress syndrome; Adult stem cells; FoxM1; Inflammation; Vascular integrity

Indexed keywords

ATAXIN 1; BETA CATENIN; CD133 ANTIGEN; CD34 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL FACTOR FOXM1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ESSENTIAL GENE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LUNG BLOOD VESSEL; LUNG INJURY; MALE; MORTALITY; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; VASCULAR SURGERY; WILD TYPE; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; RESPIRATORY DISTRESS SYNDROME, ADULT; TRANSCRIPTION INITIATION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; LIPOPOLYSACCHARIDES; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MICE, KNOCKOUT; REGENERATION; RESPIRATORY DISTRESS SYNDROME, ADULT; TRANSCRIPTIONAL ACTIVATION;

EID: 84902598307     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1690     Document Type: Article

References (45)

1. Ware LB, Matthay MA,. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
2. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353: 1685-1693.
3. Matthay MA, Ware LB, Zimmerman GA,. The acute respiratory distress syndrome. J Clin Invest 2012; 122: 2731-2740.
4. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: Summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003; 167: 1027-1035.
5. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-3561.
6. Goldenberg NM, Steinberg BE, Slutsky AS, et al. Broken barriers: A new take on sepsis pathogenesis. Sci Transl Med 2011; 3: 88ps25.
7. Lee WL, Slutsky AS,. Sepsis and endothelial permeability. N Engl J Med 2010; 363: 689-691.
8. Burnham EL, Taylor WR, Quyyumi AA, et al. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005; 172: 854-860.
9. Yamada M, Kubo H, Ishizawa K, et al. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow-derived cells contribute to lung repair. Thorax 2005; 60: 410-413.
10. Zhao YD, Ohkawara H, Rehman J, et al. Bone marrow progenitor cells induce endothelial adherens junction integrity by sphingosine-1-phosphate-mediated Rac1 and Cdc42 signaling. Circ Res 2009; 105: 696-704.
11. Wary KK, Vogel SM, Garrean S, et al. Requirement of α(4)β(1) and α(5)β(1) integrin expression in bone-marrow-derived progenitor cells in preventing endotoxin-induced lung vascular injury and edema in mice. Stem Cells 2009; 27: 3112-3120.
12. Zhao YD, Ohkawara H, Vogel SM, et al. Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability. Am J Physiol Lung Cell Mol Physiol 2010; 298: L36-L44.
13. Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007; 179: 1855-1863.
14. Mei SH, Haitsma JJ, Dos Santos CC, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010; 182: 1047-1057.
15. Krasnodembskaya A, Samarani G, Song Y, et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol 2012; 302: L1003-L1013.
16. Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15: 42-49.
17. Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009; 106: 16357-16362.
18. Lee JW, Krasnodembskaya A, McKenna DH, et al. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med 2013; 187: 751-760.
19. Danchuk S, Ylostalo JH, Hossain F, et al. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Stem Cell Res Ther 2011; 2: 27.
20. Krasnodembskaya A, Song Y, Fang X, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28: 2229-2238.
21. Ionescu L, Byrne RN, van Haaften T, et al. Stem cell conditioned medium improves acute lung injury in mice: In vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol 2012; 303: L967-L977.
22. Islam MN, Das SR, Emin MT, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012; 18: 759-765.
23. Zhao YY, Gao XP, Zhao YD, et al. Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury. J Clin Invest 2006; 116: 2333-2343.
24. Mirza MK, Sun Y, Zhao YD, et al. FoxM1 regulates re-annealing of endothelial adherens junctions through transcriptional control of beta-catenin expression. J Exp Med 2010; 207: 1675-1685.
25. Huang X, Zhao YY,. Transgenic expression of FoxM1 promotes endothelial repair following lung injury induced by polymicrobial sepsis in mice. PLoS One 2012; 7: e50094.
26. Wang IC, Chen YJ, Hughes D, et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 2005; 25: 10875-10894.
27. Laoukili J, Kooistra MR, Bras A, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 2005; 7: 126-136.
28. Costa RH,. FoxM1 dances with mitosis. Nat Cell Biol 2005; 7: 108-110.
29. Peng X, Hassoun PM, Sammani S, et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004; 169: 1245-1251.
30. Mirza MK, Yuan J, Gao XP, et al. Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation. Am J Pathol 2010; 176: 2344-2351.
31. Zhao YY, Sawyer DR, Baliga RR, et al. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 1998; 273: 10261-10269.
32. O'Reilly MA,. DNA damage and cell cycle checkpoints in hyperoxic lung injury: Braking to facilitate repair. Am J Physiol Lung Cell Mol Physiol 2001; 281: L291-L305.
33. Kotton DN, Fabian AJ, Mulligan RC,. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 2005; 33: 328-334.
34. Rojas M, Woods CR, Mora AL, et al. Endotoxin-induced lung injury in mice: Structural, functional, and biochemical responses. Am J Physiol Lung Cell Mol Physiol 2005; 288: L333-L341.
35. van Haaften T, Byrne R, Bonnet S, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009; 180: 1131-1142.
36. Gothert JR, Gustin SE, van Eekelen JA, et al. Genetically tagging endothelial cells in vivo: Bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004; 104: 1769-1777.
37. Ohle SJ, Anandaiah A, Fabian AJ, et al. Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells. Am J Respir Cell Mol Biol. 2012; 47: 11-19.
38. Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007; 104: 11002-11007.
39. Choi YH, Kurtz A, Stamm C,. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther 2011; 22: 3-17.
40. Schinkothe T, Bloch W, Schmidt A,. In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev 2008; 17: 199-206.
41. Ranganath SH, Levy O, Inamdar MS, et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012; 10: 244-258.
42. Ezaki T, Baluk P, Thurston G, et al. Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am J Pathol 2001; 158: 2043-2055.
43. Mehta D, Malik AB,. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86: 279-367.
44. Szczepaniak WS, Zhang Y, Hagerty S, et al. Sphingosine 1-phosphate rescues canine LPS-induced acute lung injury and alters systemic inflammatory cytokine production in vivo. Transl Res 2008; 152: 213-224.
45. Lee MJ, Thangada S, Claffey KP, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999; 99: 301-312.